Antimicrobial activity of some thiol-containing heterocycles.

M A Qureshi , N F Eweiss , A A Bahajaj , M A Ghannoum
Microbios 37 151 -159

21
1983
Experimental evidence for the role of lipids in adherence of Candida spp. to human buccal epithelial cells.

M A Ghannoum , G R Burns , K A Elteen , S S Radwan
Infection and Immunity 54 ( 1) 189 -193

64
1986
Mechanisms by which Candida albicans induces endothelial cell prostaglandin synthesis.

S G Filler , B O Ibe , A S Ibrahim , M A Ghannoum
Infection and Immunity 62 ( 3) 1064 -1069

37
1994
Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients.

N S Hamza , M A Ghannoum , H M Lazarus
Bone Marrow Transplantation 34 ( 5) 377 -389

36
2004
Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B.

M A Ghannoum , S G Filler , A S Ibrahim , Y Fu
Antimicrobial Agents and Chemotherapy 36 ( 10) 2239 -2244

44
1992
Interactive effects of antifungal and antineoplastic agents on yeasts commonly prevalent in cancer patients.

Ghannoum , M.A. , Motawy , M.S.
Antimicrobial Agents and Chemotherapy 33 ( 5) 726 -730

9
1989
Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth.

M A Ghannoum , M S Motawy , M A Abu Hatab , A S Ibrahim
Antimicrobial Agents and Chemotherapy 33 ( 5) 717 -725

4
1989
Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro.

M E Selsted , J E Edwards , M S Alcouloumre , M A Ghannoum
Antimicrobial Agents and Chemotherapy 37 ( 12) 2628 -2632

36
1993
Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro.

M R Yeaman , A S Ibrahim , J E Edwards , A S Bayer
Antimicrobial Agents and Chemotherapy 37 ( 3) 546 -553

62
1993
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.

M A Ghannoum , H Sanati , C F Ramos , A S Bayer
Antimicrobial Agents and Chemotherapy 41 ( 6) 1345 -1348

69
1997
Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains.

A S Bayer , M D Witt , E Kim , M A Ghannoum
Antimicrobial Agents and Chemotherapy 40 ( 2) 494 -496

7
1996
Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro.

M R Yeaman , P M Sullam , P F Dazin , M A Ghannoum
Antimicrobial Agents and Chemotherapy 38 ( 7) 1460 -1465

23
1994
Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole.

M A Ghannoum , B J Spellberg , A S Ibrahim , J A Ritchie
Antimicrobial Agents and Chemotherapy 38 ( 9) 2029 -2033

67
1994
Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.

M A Ghannoum , J H Rex , J N Galgiani
Journal of Clinical Microbiology 34 ( 3) 489 -495

159
1996
Susceptibility testing of Cryptococcus neoformans: a microdilution technique.

M A Ghannoum , A S Ibrahim , Y Fu , M C Shafiq
Journal of Clinical Microbiology 30 ( 11) 2881 -2886

131
1992
Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule.

A S Ibrahim , S G Filler , M S Alcouloumre , T R Kozel
Infection and Immunity 63 ( 11) 4368 -4374

73
1995
Reduced virulence of Candida albicans PHR1 mutants.

M A Ghannoum , B Spellberg , S M Saporito-Irwin , W A Fonzi
Infection and Immunity 63 ( 11) 4528 -4530

82
1995
Evidence implicating phospholipase as a virulence factor of Candida albicans

A S Ibrahim , F Mirbod , S G Filler , Y Banno
Infection and Immunity 63 ( 5) 1993 -1998

312
1995
Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis.

R A Fratti , M A Ghannoum , J E Edwards , S G Filler
Infection and Immunity 64 ( 11) 4714 -4718

43
1996
Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis.

M R Yeaman , S S Soldan , M A Ghannoum , J E Edwards
Infection and Immunity 64 ( 4) 1379 -1384

61
1996